Comparison of results after fluoroquinolones and combination therapies in type iiiA chronic prostatitis

• Published in: Actas urológicas españolas (English ed.) 2013-11, Vol.37 (10), p.619-624
• Main Authors: Altintas, R., Oguz, F., Beytur, A., Ediz, C., Gunes, A., Ozer, A.
• Format: Article
• Language: English
• Subjects: Alpha blocker; Bloqueador alfa; Chronic prostatitis; Fluoroquinolonas; Fluoroquinolones; Prostatitis crónica
• ISSN: 2173-5786; 2173-5786
• DOI: 10.1016/j.acuroe.2012.11.018

We investigated retrospectively the clinical outcomes of the patients with type iii inflammatory chronic prostatitis, who were treated with fluoroquinolones with and without an α-blocker between 2009 and 2011. Diagnosis was established with medical history (symptoms presented longer than 3 months within previous 6 months), physical examination, Meares-Stamey test and the questionnaire of the NIH-CPSI. The responses to the treatment were assessed with uroflowmetry test and the questionnaire of NIH-CPSI at initial and after 4 weeks of the treatment. The patients with incomplete data and treatment and who treated with α-blockers and/or antibiotics in the period 4 weeks prior to the therapy started in our clinic and had any surgery of lower urinary tract previously were excluded. The patients were classified under 6 groups: group1=ciprofloxacin, group2=ofloxacin, group3=levofloxacin, group4=ciprofloxacin+tamsulosin, group5=ofloxacin+tamsulosin, group 6=levofloxacin+tamsulosin. Wilcoxon Signed Ranks and Kruskal Wallis test were used for comparison of results. Mann Whitney U test with Bonferroni correction made was used as post hoc (p